Alpelisib Structural Formula (Vijoice 01)
Vijoice Kit
Product Images NDC 0078-1035
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vijoice (NDC 0078-1035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel Vijoice™ (alpelisib) Tablets Ndc 0078-1021-84 50 mg Daily Dose Take One 50 mg Tablet Once Daily Rx Only Recommended Dosage: Take One 50 mg Tablet Once Daily With Food. Swallow Tablets Whole. Do Not Chew, Crush, Or Split Tablets. See Prescribing Information For Complete Dosage Information And Instruction For Patients Who Are Unable To Swallow Whole Tablets. 28-day Supply Contains: One Blister Pack Containing 28 Tablets Novartis (Vijoice 02)
This text is a product description of a medication called "Vijoice", which contains 50 mg of alpelisib, manufactured by Novartis Pharma Stain AG in Switzerland and distributed by Novartis Pharmaceuticals Corporation in New Jersey, USA. The medication is intended for oral use and the recommended dosage is one 50 mg tablet once daily with food. The tablets should not be chewed, crushed, or split. The medication comes in a blister pack containing 28 tablets and should be stored at 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (50°F and 86°F) in the original package to keep away from children. For more information, there is a website link and phone number provided.*
Principal Display Panel Vijoice™ (alpelisib) Tablets Ndc 0078-1028-84 125 mg Daily Dose Take One 125 mg Tablet Once Daily Rx Only Recommended Dosage: Take One 125 mg Tablet Once Daily With Food. Swallow Tablets Whole. Do Not Chew, Crush, Or Split Tablets. See Prescribing Information For Complete Dosage Information And Instruction For Patients Who Are Unable To Swallow Whole Tablets. 28-day Supply Contains: One Blister Pack Containing 28 Tablets Novartis (Vijoice 03)
Vijoice tablets containing alpelisib (125 mg) are a prescription medication indicated for oral use to treat certain types of breast cancer. The medication is manufactured by Novartis Pharma Stain AG in Switzerland and distributed by Novartis Pharmaceuticals Corporation in the US. The medication should be taken once daily with food and swallowed whole. The medication is not suitable for chewing, crushing or splitting. Detailed prescribing information is available for those who cannot swallow the tablets whole. The medication should be stored at temperatures between 20°C to 25°C (68°F to 77°F). The packaging contains a 28-day supply and the medication should be kept out of reach of children. For more information, patients are advised to refer to the product website or contact Novartis Pharmaceuticals Corporation customer support.*
Principal Display Panel Vijoice™ (alpelisib) Tablets Ndc 0078-1035-02 250 mg Daily Dose Take One 200 mg Tablet And One 50 mg Tablet Once Daily Rx Only Recommended Dosage: Take One 200 mg Tablet And One 50 mg Tablet Once Daily With Food. Swallow Tablets Whole. Do Not Chew, Crush, Or Split Tablets. See Prescribing Information For Complete Dosage Information And Instruction For Patients Who Are Unable To Swallow Whole Tablets. 28-day Supply (56 Tablets): Contains: Two 14-day Blister Packs Each Containing 28 Tablets: 200 mg 14 Tablets Per Pack 50 mg 14 Tablets Per Pack Novartis (Vijoice 04)
This is a description of Vijoice, a medication made by Novartis Pharma Stein AG of Switzerland and distributed by Novartis Pharmaceuticals Corporation of New Jersey. This is a recommended medication for oral use and should be taken by swallowing one 200 mg tablet and one 50 mg tablet whole once daily with food. It is important not to crush, chew, or split the tablets. Vijoice comes in two 14-day blister packs each containing 28 tablets. The prescribing information contains complete dosage information and instructions for patients who are unable to swallow tablets. The storage temperature should be between 20°C to 25°C (68°F to 77°F) and out of the reach of children. For more information, visit www.VIOICE.com or call 1-888-669-6682.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
